CCI Région Bourgogne Franche-Comté is organizing a B2B matching event within the frame of the scientific congress Innovative Therapies Days.
Mochida Pharmaceutical’s open innovation programme
Since 2019, the company is managing its MOIRe (Mochida Open Innovation Research) programme and is now inviting researchers and research representatives affiliated with public research institutions, universities, etc. to submit proposals for collaborative research.
Introduction of Global Biocommunities: Biocommunity Kansai “BiocK”
Biocommunity Kansai “BiocK” is one of the first global Biocommunities in Japan, established in July 2021 and certified by the Japanese cabinet office in April 2022, based on the Japanese cabinet office's Bioeconomy Strategy "Realization of the World's Most Advanced Bioeconomy Society".
Webinar : Doing Biotech Business In Japan
Doing business in Japan can be challenging in many ways. It is why the European cluster alliance bioXclusters is glad to invite you to participate to its next webinar focusing on « Doing Business In Japan » on 11 May 2023, at 9:00 CET.
Find your partner in Japan
YOU ARE AN EU SME and YOU WANT TO INTERNATIONALISE ?
FIND YOUR PARTNER IN JAPAN !
TAKE ADVANTAGE OF THE FOLLOWING SERVICES :
Osaka and Munich continue their successful partnership
The cluster management organizations BioM, based in Munich, Germany, and Osaka Bio Headquarters, based in Osaka, Japan, officially announced the renewal of their long-standing Transnational Biotech & Life Sciences Cooperation Partnership Agreement on the occasion of the EU-Japan Biotech & Pharma Partnering Conference 2022 in Osaka.
Case Study - TreeFrog Therapeutics
TreeFrog Therapeutics (https://treefrog.fr/) is a French biotechnology company specialized in cell therapy. In April 2022, Treefrog announced the opening of a lab in Kobe, Japan, with the aim of establishing strategic alliances with key academic and industrial players in the field of regenerative medicine.
Discover the company’s reception in Japan, their encountered challenges, and recommendations to other EU SMEs by reading our Case Study.
Biotech Cluster and SME Mission to Japan
Representatives from 10 EU Biotech companies from 7 EU member states travelled to Osaka and Yokohama to meet Japanese life sciences and pharma companies.
Joint venture established in 1987 by the European Commission (DG GROW) and the Japanese Government (METI) for promoting all forms of industrial, trade and investment cooperation between the EU and Japan.